Efficacy of ZnPcS2P2 photodynamic therapy solely or with tumor vaccines on mouse tumor models

Photodiagnosis and Photodynamic Therapy

Volumn 4, Issue 2, 2007, Pages 100-105

  Huang, Hui Fang ^a   Chen, Yuan Zhong ^a   Wu, Yong ^a   Li, Nai Nong ^a   Chen, Ping ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

Immune gene therapy; Leukemia; Lymphoma; Photodynamic therapy; Zinc phthalocyanine

Indexed keywords

B7 ANTIGEN; DISULFO DIPHTHALIMIDOMETHYL PHTHALOLCYANINE ZINC; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; PHOTOSENSITIZING AGENT; TUMOR CELL VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; LEUKEMIA; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SURVIVAL TIME; THYMUS LYMPHOMA; TUMOR GROWTH; TUMOR MODEL; TUMOR XENOGRAFT;

MUS; MUS MUSCULUS;

EID: 34248140672     PISSN: 15721000     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pdpdt.2007.02.001     Document Type: Article

References (33)

1. Niedre M., Patterson M.S., and Wilson B.C. Direct near-infrared luminescence detection of singlet oxygen generated by photo-dynamic therapy in cells in vitro and tissues in vivo. Photochem photobiol 75 (2002) 382-391
2. Casas A., Fukuda H., Venosa G.D., and Batlle A. Photosensitization and mechanism of cytotoxicity induced by the use of ALA derivatives in photodynamic therapy. Br J Cancer 85 (2001) 279-284
3. Furre I.E., Shahzidi S., Luksiene Z., et al. Targeting PBR by hexaminolevulinate-mediated photodynamic therapy induces apoptosis through translocation of apoptosis-inducing factor in human leukemia cells. Cancer Res 65 (2005) 11051-11060
4. Lee W.Y., Lim W.Y., Lim D.S., et al. Photoactivation of pheophorbide a induces a mitochondrial-mediated apoptosis in Jurkat leukaemia cells. J Photochem Photobiol B 75 (2004) 119-126
5. Zhang S.J., and Zhang Z.X. 5-Aminolevulinic acid-based photodynamic therapy in leukemia cell HL60. Photochem Photobiol 79 (2004) 545-550
6. Kuzelova K., Grebenova D., Pluskalova M., Marinov I., and Hrkal Z. Early apoptotic features of K562 cell death induced by 5-aminolaevulinic acid-based photodynamic therapy. J Photochem Photobiol B 73 (2004) 67-78
7. Jin Z.H., Miyoshi N., Ishiguro K., et al. Photodynamic therapy based on combined use of 5-aminolevulinic acid with a pheophorbide-a derivative for murine tumors. In Vivo 14 (2000) 529-533
8. Canti G., Nicolin A., Cubeddu R., Taroni P., Bandieramonte G., and Valentini G. Antitumor efficacy of the combination of photodynamic therapy and chemotherapy in murine tumors. Cancer Lett 125 (1998) 39-44
9. Canti G., Lattuada D., Morelli S., et al. Efficacy of photodynamic therapy against doxorubicin-resistant murine tumors. Cancer Lett 93 (1995) 255-259
10. Delaey E., Zupko I., Chen B., et al. Comparison of hexamethylhypericin and tetrabromohypericin to hypericin for their in vivo efficacy as PDT tools. Int J Oncol 23 (2003) 519-524
11. Huang J.L., Chen N.S., Huang J.D., et al. Synthesis, peculiarity and anti-tumor potency of the double affinity photosensitizer-zinc phthalocyanine. Sci China B 30 (2000) 481-488
12. Huang J.L., Chen N.S., Huang J.D., et al. Metal phthalocyanine as photosensitizer for photodynamic therapy (PDT). Sci China B 44 (2001) 113-122
13. 2-based-photodynamic therapy on bone marrow purging. Chin Med J 118 (2005) 105-110
14. 2-based-photodynamic therapy. Bone Marrow Transplant 37 (2006) 213-217
15. 2 in HL60 cell. Acta Pharmacol Sin 26 (2005) 1138-1144
16. 2-based-photodynamic therapy induces mitochondria-dependent apoptosis in K562 cells. Acta Biochim Biophys Sin 37 (2005) 488-494
17. van Duijnhoven F.H., Aalbers R.I., Rovers J.P., Terpstra O.T., and Kuppen P.J. The immunological consequences of photodynamic treatment of cancer, a literature review. Immunobiology 207 (2003) 105-113
18. Sun J., Cecic I., Parkins C.S., and Korbelik M. Neutrophils as inflammatory and immune effectors in photodynamic therapy-treated mouse SCCVII tumours. Photochem Photobiol Sci 1 (2002) 690-695
19. Gollnick S.O., Vaughan L., and Henderson B.W. Generation of effective antitumor vaccines using photodynamic therapy. Cancer Res 62 (2002) 1604-1608
20. King D.E., Jiang H., Simkin G.O., Obochi M.O., Levy J.G., and Hunt D.W. Photodynamic alteration of the surface receptor expression pattern of murine splenic dendritic cells. Scand J Immunol 49 (1999) 184-192
21. Korbelik M., Krosl G., Krosl J., and Dougherty G.J. The role of host lymphoid populations in the response of mouse EMT6 tumor to photodynamic therapy. Cancer Res 56 (1996) 5647-5652
22. Yanai H., Kuroiwa Y., Shimizu N., et al. The pilot experience of immunotherapy-combined photodynamic therapy for advanced gastric cancer in elderly patients. Int J Gastrointest Cancer 32 (2002) 139-142
23. Dima V.F., Ionescu M.D., Balotescu C., Dima S.V., Vasiliu V., and Lacky D. New approach to the adoptive immunotherapy of Walker-256 carcinosarcoma with activated macrophages combined with photodynamic therapy. Roum Arch Microbiol Immunol 60 (2001) 237-256
24. Korbelik M., and Sun J. Cancer treatment by photodynamic therapy combined with adoptive immunotherapy using genetically altered natural killer cell line. Int J Cancer 93 (2001) 269-274
25. Korbelik M., Sun J., and Posakony J.J. Interaction between photodynamic therapy and BCG immunotherapy responsible for the reduced recurrence of treated mouse tumors. Photochem Photobiol 73 (2001) 403-409
26. Korbelik M., Naraparaju V.R., and Yamamoto N. Macrophage-directed immunotherapy as adjuvant to photodynamic therapy of cancer. Br J Cancer 75 (1997) 202-207
27. Krosl G., and Korbelik M. Potentiation of photodynamic therapy by immunotherapy: the effect of schizophyllan (SPG). Cancer Lett 84 (1994) 43-49
28. ® based photodynamic therapy by localized treatment with G-CSF. Br J Cancer 82 (2000) 1485-1491
29. Krosl G., Korbelik M., Krosl J., and Dougherty G.J. Potentiation of photodynamic therapy-elicited antitumor response by localized treatment with granulocyte-macrophage colony-stimulating factor. Cancer Res 56 (1996) 3281-3286
30. Nakazaki Y., Tani K., Lin Z.T., et al. Vaccine effect of granulocyte-macrophage colony-stimulating factor or CD80 gene-transduced murine hematopoietic tumor cells and their cooperative enhancement of antitumor immunity. Gene Ther 5 (1998) 1355-1362
31. + cells from Gaucher patients. Blood 86 (1995) 141-146
32. Nemati F., Livartowski A., Cremoux P.D., et al. Distinctive potentiating effects of cisplantin and/or ifosfamide combined with etoposide in human small cell lung carcinoma xenografts. Clin Cancer Res 6 (2000) 2075-2086
33. Goff B.A., Blake J., Bamberg M.P., and Hasan T. Treatment of ovarian cancer with photodynamic therapy and immunoconjugates in a murine ovarian cancer model. Br J Cancer 74 (1996) 1194-1198